Correspondence 0001193125-24-253134 from BIODESIX INC (BDSX) (CIK 0001439725) (BDSX)
BIODESIX INC (BDSX) (CIK 0001439725)
Date: Nov. 7, 2024 · CIK: 0001439725 · Accession: 0001193125-24-253134
AI Filing Summary & Sentiment
File numbers found in text: 333-282938
Show Raw Text
CORRESP 1 filename1.htm CORRESP November 7, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Conlon Danberg Re: Acceleration Request for Biodesix, Inc. Registration Statement on Form S-3 (File No. 333-282938) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biodesix, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-3, Registration Number 333-282938, (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M., Eastern Time or as soon thereafter as practicable, on November 12, 2024, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. [Signature Page Immediately Follows] We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Samir A. Gandhi of Sidley Austin LLP at (212) 839-5684. Very truly yours, /s/ Robin Harper Cowie Robin Harper Cowie Chief Financial Officer cc: Scott Hutton, Biodesix, Inc. Frank F. Rahmani, Sidley Austin LLP